Applied Finance Capital Management LLC Reduces Holdings in Stryker Corporation $SYK

Posted by George Bondi on May 16th, 2026

Applied Finance Capital Management LLC trimmed its holdings in shares of Stryker Corporation (NYSE:SYK – Free Report) by 10.1% in the fourth quarter, HoldingsChannel reports. The firm owned 29,742 shares of the medical technology company’s stock after selling 3,337 shares during the period. Applied Finance Capital Management LLC’s holdings in Stryker were worth $10,454,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of SYK. United Financial Planning Group LLC acquired a new stake in Stryker during the third quarter worth approximately $27,000. CGC Financial Services LLC acquired a new stake in Stryker during the fourth quarter worth approximately $29,000. Strive Asset Management LLC acquired a new stake in Stryker during the third quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new stake in Stryker during the third quarter worth approximately $34,000. Finally, Copia Wealth Management boosted its position in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after acquiring an additional 69 shares during the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In related news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the sale, the vice president owned 177 shares of the company’s stock, valued at $50,170.65. The trade was a 95.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

SYK has been the topic of a number of analyst reports. Wells Fargo & Company decreased their target price on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. William Blair restated an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Jefferies Financial Group restated a “buy” rating and set a $465.00 target price on shares of Stryker in a research report on Wednesday, March 4th. Piper Sandler restated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, UBS Group decreased their target price on shares of Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Sixteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Check Out Our Latest Research Report on SYK

Stryker Stock Performance

NYSE:SYK opened at $306.74 on Friday. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $117.59 billion, a price-to-earnings ratio of 35.50, a PEG ratio of 1.92 and a beta of 0.80. The firm’s fifty day simple moving average is $329.68 and its 200 day simple moving average is $351.73. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $404.87.

Stryker (NYSE:SYK – Get Free Report) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same quarter in the previous year, the firm posted $2.84 EPS. The business’s revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s payout ratio is 40.74%.

About Stryker

(Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.